Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Gilteritinib as a bridge to allogeneic hematopoietic stem cell transplantation in adult patients with refractory/relapsed acute myeloid leukemia with FLT3 mutations

Bella Ayubova, ,Sergey Bondarenko,Anna Smirnova,Yulia Vlasova, Nikolay Tsvetkov, Michail Kanunnikov, Dmitry Zhogolev, Yuliya Oleynikova,Elena Karyagina, Ridvan Ilyasov, Natalya Zorina, Svetlana Belyaeva, Yulia Neredko, Irina Samorodova, Yulia Chernih, Mikhail Lazarev, Anna Kochergina, Anna Nasredinova,Ildar Barkhatov,Tatyana Gindina,Ivan Moiseev,Alexander Kulagin, , , , , , , , , , , , , , , , , , , , ,

Cellular therapy and transplantation（2022）

Cited 0|Views1
No score
Abstract
Гилтеритиниб как «мост»-терапия перед аллогенной трансплантацией костного мозга у пациентов с рефрактерным/рецидивирующим острым миелоидным лейкозом с мутацией в гене FLT3Gilteritinib as a bridge to allogeneic hematopoietic stem cell transplantation in adult patients with refractory/relapsed acute myeloid leukemia with FLT3 mutations
More
Translated text
Key words
acute myeloid leukemia,hematopoietic stem cell transplantation,hematopoietic stem,mutations
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined